Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
151,865,218
-
Total 13F shares
-
114,044,316
-
Share change
-
+2,261,282
-
Total reported value
-
$6,743,577,628
-
Put/Call ratio
-
40%
-
Price per share
-
$59.13
-
Number of holders
-
244
-
Value change
-
+$149,068,690
-
Number of buys
-
126
-
Number of sells
-
95
Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q4 2020
As of 31 Dec 2020 Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) had 244 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 114,044,316 shares of stock of the company.
Largest 10 holders included VIKING GLOBAL INVESTORS LP, Matrix Capital Management Company, LP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., MASSACHUSETTS FINANCIAL SERVICES CO /MA/, GILDER GAGNON HOWE & CO LLC, Artisan Partners Limited Partnership, Neuberger Berman Group LLC, and FMR LLC.
This table shows 244 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.